Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A tumor composed of two or more glial cell types (astrocytes, ependymal cells, and oligodendrocytes).
Biomarker and diagnostic research for mixed glioma has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE1. Research is primarily sponsored by academic and government institutions.
244 publications have been identified in PubMed for mixed glioma. Research spans Basic Science / Preclinical (50%), Review / Meta-Analysis (28%), and Gene Therapy / Novel Therapeutics (9%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 123 |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 7:14 PM UTC
Research summaries | 69 | 28% |
New treatment approaches | 23 | 9% |
Testing and diagnosis research | 14 | 6% |
Disease patterns and progression | 8 | 3% |
Clinical study results | 5 | 2% |
Other research | 2 | 1% |
Yu KKH (2026). [PMID: 41529664](https://pubmed.ncbi.nlm.nih.gov/41529664/). *Cancer Cell*. [Basic Science / Preclinical]
Ding C (2026). [PMID: 41747254](https://pubmed.ncbi.nlm.nih.gov/41747254/). *Cancer Discov*. [Basic Science / Preclinical]
Sarikonda A (2026). [PMID: 40521909](https://pubmed.ncbi.nlm.nih.gov/40521909/). *Oper Neurosurg*. [Clinical Trial Publication]
Zhang L (2026). [PMID: 41294275](https://pubmed.ncbi.nlm.nih.gov/41294275/). *J Mol Cell Biol*. [Basic Science / Preclinical]
Guarnaccia M (2026). [PMID: 41249878](https://pubmed.ncbi.nlm.nih.gov/41249878/). *Ann Clin Transl Neurol*. [Review / Meta-Analysis]
Hasani F (2026). [PMID: 41503680](https://pubmed.ncbi.nlm.nih.gov/41503680/). *J Cell Mol Med*. [Review / Meta-Analysis]
McAlpine H (2026). [PMID: 41298888](https://pubmed.ncbi.nlm.nih.gov/41298888/). *Nature neuroscience*. [Basic Science / Preclinical]
Tralongo P (2026). [PMID: 42220436](https://pubmed.ncbi.nlm.nih.gov/42220436/). *Oncol Res*. [Review / Meta-Analysis]
Jaju A (2026). [PMID: 41274770](https://pubmed.ncbi.nlm.nih.gov/41274770/). *Neuroimaging clinics of North America*. [Basic Science / Preclinical]
Schipmann S (2026). [PMID: 42165835](https://pubmed.ncbi.nlm.nih.gov/42165835/). *Recent Results Cancer Res*. [Review / Meta-Analysis]